# Denali Therapeutics Inc. (DNLI) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$555M |
| 2024 | -$487M |
| 2023 | -$197M |
| 2022 | -$341M |
| 2021 | -$296M |
| 2020 | $63M |
| 2019 | -$213M |
| 2018 | -$46M |
| 2017 | -$90M |
| 2016 | -$87M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2024-09-30 | -$123M |
| 2024-06-30 | -$117M |
| 2024-03-31 | -$118M |
| 2023-09-30 | -$114M |
| 2023-06-30 | $170M |
| 2023-03-31 | -$121M |
| 2022-09-30 | -$107M |
| 2022-06-30 | -$61M |
| 2022-03-31 | -$66M |
| 2021-09-30 | -$86M |
| 2021-06-30 | -$62M |
| 2021-03-31 | -$71M |
| 2020-09-30 | -$60M |
| 2020-06-30 | -$61M |
| 2020-03-31 | -$60M |
| 2019-09-30 | -$50M |
| 2019-06-30 | -$63M |
| 2019-03-31 | -$43M |
| 2018-09-30 | -$38M |
| 2018-06-30 | -$57M |
| 2018-03-31 | -$26M |
| 2017-09-30 | -$22M |
| 2017-06-30 | -$23M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/DNLI/operating-income)